BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10687205)

  • 1. [Effect of enalapril maleate on vascular endothelial function and platelet-endothelial interactions in patients with essential hypertension].
    Iakovlev VM; Semenkin AA; Iudin SM; Nazarov AG; Kudriashov IL; Potapov VV; Korennova OIu; Il'iunykh LN
    Ter Arkh; 2000; 72(1):40-4. PubMed ID: 10687205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries.
    Erzen B; Gradisek P; Poredos P; Sabovic M
    Angiology; 2006; 57(2):187-92. PubMed ID: 16518526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
    Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Aug; 31(8):1676-82. PubMed ID: 23625113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.
    Tezcan H; Yavuz D; Toprak A; Akpinar I; Koç M; Deyneli O; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):119-23. PubMed ID: 12806595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
    Vizir VA; Berezin AE
    Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
    Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF; Bareford D; Beevers DG
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D; Porteri E; De Ciuceis C; Sleiman I; Rodella L; Rezzani R; Paiardi S; Bianchi R; Ruggeri G; Boari GE; Muiesan ML; Salvetti M; Zani F; Miclini M; Rosei EA
    Hypertension; 2005 Apr; 45(4):659-65. PubMed ID: 15723969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between changes of endothelial vasodilator function, vascular and cardiac structure and derangements of blood pressure 24-hour profile].
    Ripp TM; Mordovin VF; Pekarskiĭ SE
    Kardiologiia; 2003; 43(1):36-9. PubMed ID: 12891284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension.
    Remková A; Kratochvíl'ová H
    J Hum Hypertens; 2002 Aug; 16(8):549-55. PubMed ID: 12149660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
    Li-Saw-Hee FL; Beevers DG; Lip GY
    Int J Cardiol; 2001 May; 78(3):241-6. PubMed ID: 11376827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early effects of enalapril in patients with chronic cerebral ischemia and arterial hypertension].
    Klin Med (Mosk); 2011; 89(6):59-62. PubMed ID: 22420198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitor effects on platelet function in stages I-II hypertension.
    Moser L; Callahan KS; Cheung AK; Stoddard GJ; Munger MA
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):461-7. PubMed ID: 9335405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
    Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.